Irish startup reports mid-stage victory for short-acting psychedelic drug in depression

GH Re­search has shared com­pelling da­ta in peo­ple with a tra­di­tion­al­ly chal­leng­ing form of de­pres­sion who were dosed with its psy­che­del­ic can­di­date, de­spite the drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.